D. M. Ross

Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm- overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.

A. Enjeti, I. Tiong, A. Grigg, 2022, Pathology.

Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia

Anna L. Brown, Mahmoud A. Bassal, U. Roessner, 2022, Nature Communications.

Targeting human CALR‐mutated MPN progenitors with a neoepitope‐directed monoclonal antibody

A. Reinisch, M. Dottore, Angel F. Lopez, 2022, EMBO reports.

Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.

Anna L. Brown, R. D'Andrea, H. Scott, 2022, Pathology.

Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long‐term treatment with subcutaneous protein C concentrate

A. Gallus, Nancy V Lerda, D. M. Ross, 2016, British journal of haematology.

Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis

D. Mclornan, Vikas Gupta, K. Gowin, 2022, American journal of hematology.